Cerity Partners’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482K Sell
46,241
-6,334
-12% -$70.7K ﹤0.01% 2455
2026
Q1
$626K Buy
52,575
+35,772
+213% +$366K ﹤0.01% 2149
2025
Q4
$167K Buy
16,803
+882
+6% +$8.42K ﹤0.01% 2680
2025
Q3
$142K Buy
15,921
+4,934
+45% +$45.7K ﹤0.01% 2574
2025
Q2
$104K Buy
+10,987
New +$96.9K ﹤0.01% 2471
2024
Q2
Sell
-35,485
Closed -$408K 2228
2024
Q1
$408K Buy
+35,485
New +$301K ﹤0.01% 1706

Other funds holding AHCO

Cerity Partners's AHCO Position: Q2 2026 in Review

Cerity Partners reduced its AdaptHealth (AHCO) stake by 12% in Q2 2026, selling an estimated $70.7K and leaving 46,241 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

Cerity Partners first reported a position in AHCO in Q1 2024 and has held it in 6 quarters since. The position peaked at $626K in Q1 2026. 215 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Cerity Partners held 46,241 shares of AdaptHealth worth $482K as of Q2 2026.
  • Cerity Partners sold 6,334 AdaptHealth shares in Q2 2026, an estimated $70.7K.
  • AdaptHealth made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2455 holding.
  • Cerity Partners first reported a position in AdaptHealth in Q1 2024 and has held it in 6 quarters since.
  • Cerity Partners's AdaptHealth position peaked at $626K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.